ESMO 2021 - Artificial Intelligence predicts the risk of recurrence for women with the most common breast cancer

 The RACE AI study conducted by Gustave Roussy and the startup Owkin, as part of the AI for Health Challenge organized by the Ile-de-France Region in 2019, was presented as a proffered paper at ESMO (European Society of Medical Oncology). This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years .

Speeding up Breast Cancer Diagnosis in Egypt: GE Healthcare, Gustave Roussy and the Egypt Ministry of Health Partner to Create Rapid Breast Cancer Diagnosis Clinics

Cairo, Egypt and Villejuif & Buc, France – September 7, 2021

Speeding up Breast Cancer Diagnosis in Egypt: GE Healthcare, Gustave Roussy and the Egypt Ministry of Health Partner to Create Rapid Breast Cancer Diagnosis Clinics

GE Healthcare, Gustave Roussy and the Egypt Ministry of Health (MOH) signed a preliminary agreement leveraging Gustave Roussy’s One Stop Breast Cancer diagnostics program to increase the speed and the accuracy of breast cancer diagnosis in Egypt.

Biography Françoise Rimareix

Doctor Françoise Rimareix

Françoise RimareixA plastic and reconstructive surgeon and a specialist in senology, Dr Françoise Rimareix has been the Medical Director of Gustave Roussy since 1st September 2021.

Infirmiers, Infirmières IDE de nuit

Infirmières, Infirmiers de nuit

Gustave Roussy, leader européen de la cancérologie, recrute des Infirmier(e)s jeunes diplômé(e)s ou expérimenté(e)s, en CDI ou en CDD.

Gustave Roussy propose des postes d'infirmier(e)s de nuit en 12h sur 125 nuits par an.

Good to know 10

Newsletter Good to Know : l'actualité scientifique en cancérologie, vue par Gustave Roussy.

Pages